{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:56:42Z","timestamp":1773323802735,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.urology.2006.09.064","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T09:27:24Z","timestamp":1172136444000},"page":"245-250","source":"Crossref","is-referenced-by-count":8,"title":["Radical Hypofractionated Accelerated Radiotherapy with Cytoprotection for Invasive Bladder Cancer"],"prefix":"10.1016","volume":"69","author":[{"given":"Michael I.","family":"Koukourakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Tsolos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Touloupidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2006.09.064_bib1","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2002.11.027","article-title":"Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results","volume":"20","author":"Rodel","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(97)00579-8","article-title":"Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer","volume":"40","author":"Sauer","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0167-8140(91)90033-D","article-title":"Dose fractionation and tumour repopulation in radiotherapy for bladder cancer","volume":"21","author":"Maciejewski","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2004.02.056","article-title":"Clinical radiobiology of stage T2-T3 bladder cancer","volume":"60","author":"Majewski","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0360-3016(98)00263-6","article-title":"Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control","volume":"42","author":"Moonen","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2004.11.003","article-title":"A randomised trial of accelerated radiotherapy for localised invasive bladder cancer","volume":"75","author":"Horwich","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-8140(96)01893-2","article-title":"Hypofractionated radiotherapy for invasive bladder cancer","volume":"43","author":"Scholten","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/clon.1999.9075","article-title":"Hypofractionated radiotherapy for patients with carcinoma of the bladder","volume":"11","author":"Jose","year":"1999","journal-title":"Clin Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1634\/theoncologist.5-6-471","volume":"5","author":"Kaufman","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.urology.2006.09.064_bib10","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ijrobp.2005.09.023","article-title":"Radical radiotherapy for invasive bladder cancer: what dose and fractionation schedule to choose?","volume":"64","author":"Pos","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib11","first-page":"3239","article-title":"Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience","volume":"24","author":"Koukourakis","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urology.2006.09.064_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0360-3016(01)01759-X","article-title":"Tumor and Angiogenesis Research Group: Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients","volume":"52","author":"Koukourakis","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 11","key":"10.1016\/j.urology.2006.09.064_bib13","first-page":"33","article-title":"The biodistribution and pharmacokinetics of stealth liposomes in patients with solid tumors","volume":"11","author":"Stewart","year":"1997","journal-title":"Oncology"},{"key":"10.1016\/j.urology.2006.09.064_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/028418600430789","article-title":"High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas\u2014rationale for combination with radiotherapy","volume":"39","author":"Koukourakis","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib15","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1200\/JCO.1999.17.11.3512","article-title":"Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer","volume":"17","author":"Koukourakis","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0958-3947(16)30037-1","article-title":"LQ-based model for biological radiotherapy planning","volume":"19","author":"Koukourakis","year":"1994","journal-title":"Med Dosim"},{"key":"10.1016\/j.urology.2006.09.064_bib17","first-page":"2437","article-title":"Individualization of the subcutaneous amifostine dose during hypofractionated\/accelerated radiotherapy","volume":"26","author":"Koukourakis","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urology.2006.09.064_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijrobp.2004.02.026","article-title":"Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP)","volume":"60","author":"Boccia","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(97)06305-8","article-title":"Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomized multicentre trial","volume":"350","author":"Saunders","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2006.09.064_bib21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ijc.1034","article-title":"Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin","volume":"96","author":"Zouhair","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2006.09.064_bib22","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.1996.14.11.2901","article-title":"Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation","volume":"14","author":"Coppin","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0360-3016(96)00063-6","article-title":"Once weekly irradiation for carcinoma of the bladder","volume":"35","author":"Rostom","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0360-3016(00)00430-2","article-title":"A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of Medical Research Council Trial BA09","volume":"47","author":"Duchesne","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0167-8140(97)01943-9","article-title":"Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly","volume":"43","author":"McLaren","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2003.10.018","article-title":"Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy","volume":"59","author":"Cowan","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib27","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0360-3016(03)00187-1","article-title":"Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial","volume":"56","author":"Athanassiou","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2006.09.064_bib28","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib29","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1200\/JCO.2001.19.20.4005","article-title":"Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC","volume":"19","author":"Millikan","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2006.09.064_bib30","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0959-8049(03)00358-7","article-title":"Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract","volume":"39","author":"Winquist","year":"2003","journal-title":"Eur J Cancer"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950602334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950602334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T17:17:27Z","timestamp":1556126247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042950602334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S009042950602334X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2006.09.064","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}